ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
SPDR MSCI USA Gender Diversity ETF

SPDR MSCI USA Gender Diversity ETF (SHE)

108.82
0.0807
(0.07%)
At close: July 29 4:00PM
108.82
0.00
( 0.00% )
After Hours: 4:15PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
108.82
Bid
-
Ask
-
Volume
1,753
108.7749 Day's Range 109.17
82.1375 52 Week Range 112.64
Market Cap
Previous Close
108.7393
Open
109.17
Last Trade
103
@
108.82
Last Trade Time
18:30:00
Financial Volume
$ 190,898
VWAP
108.898
Average Volume (3m)
3,600
Shares Outstanding
2,375,000
Dividend Yield
-
PE Ratio
7.85
Earnings Per Share (EPS)
13.87
Revenue
3.67M
Net Profit
32.95M

About SPDR MSCI USA Gender Diversity ETF

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SSGA Gender Diversity Index, which tracks U. Under normal market conditions, the fund generally invests substantially all, but at least 80%, of its total ass... The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SSGA Gender Diversity Index, which tracks U. Under normal market conditions, the fund generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. In addition, it may invest in equity securities that are not included in the index, cash and cash equivalents or money market instruments. The fund is non-diversified. Show more

Sector
Mgmt Invt Offices, Open-end
Industry
Mgmt Invt Offices, Open-end
Headquarters
Boston, Massachusetts, USA
Founded
1970
SPDR MSCI USA Gender Diversity ETF is listed in the Mgmt Invt Offices, Open-end sector of the American Stock Exchange with ticker SHE. The last closing price for SPDR MSCI USA Gender Div... was $108.74. Over the last year, SPDR MSCI USA Gender Div... shares have traded in a share price range of $ 82.1375 to $ 112.64.

SPDR MSCI USA Gender Div... currently has 2,375,000 shares outstanding. The market capitalization of SPDR MSCI USA Gender Div... is $258.26 million. SPDR MSCI USA Gender Div... has a price to earnings ratio (PE ratio) of 7.85.

SHE Latest News

PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch

 PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch Delivering psilocybin via microneedle patch unlocks potential for desired dosage forms and pharmacokinetic profiles...

PharmaTher Enters into Research Collaboration Agreement with Revive Therapeutics for Development of Psilocybin Microneedle Patch

 PharmaTher Enters into Research Collaboration Agreement with Revive Therapeutics for Development of Psilocybin Microneedle Patch  Focusing on partnership model for MicroDose-MN™ and...

PharmaTher Engages Alcami for Clinical and Commercial Manufacturing of Novel Ketamine Products

 PharmaTher Engages Alcami for Clinical and Commercial Manufacturing of Novel Ketamine Products Leading U.S.-based CDMO to manufacture PharmaTher's proprietary ketamine products for FDA Phase 3...

PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Complex Regional Pain Syndrome

 PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Complex Regional Pain Syndrome Achieving its second FDA orphan drug designation with ketamine.Building a proprietary...

PharmaTher Added to the North American Psychedelics Index and First Psychedelic Exchange Traded Fund

 PharmaTher Added to the North American Psychedelics Index and First Psychedelic Exchange Traded Fund TORONTO, September 21, 2021 -- InvestorsHub NewsWire -- PharmaTher Holdings Ltd. (the...

PharmaTher Provides Product Pipeline Updates and Anticipated Milestones for Q4-2021 and 2022

  PharmaTher Provides Product Pipeline Updates and Anticipated Milestones for Q4-2021 and 2022   10 clinical sites selected to participate in the FDA Phase 2 clinical...

PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Amyotrophic Lateral Sclerosis

 PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Amyotrophic Lateral Sclerosis Focusing on becoming a global leader in prescription-based ketamine productsAdvancing to a Phase...

PharmaTher Expands Psychedelic Patent Portfolio with Filing of U.S. Patent Application for Novel Ketamine Formulation

 PharmaTher Expands Psychedelic Patent Portfolio with Filing of U.S. Patent Application for Novel Ketamine Formulation Strengthens position to become a leader in the intradermal delivery of FDA...

PharmaTher Files FDA Pre-IND Meeting Request and Briefing Package For KETABET™ To Treat Depression

  PharmaTher Files FDA Pre-IND Meeting Request and Briefing Package For KETABET™ To Treat Depression   Potential for FDA 505(b)(2) regulatory pathway approval and...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.34-1.21641249092110.16110.694107.92397108.95050576SP
4-0.21-0.192607539209109.03112.64107.93013109.94647779SP
125.635.4559550344103.19112.64103.193600107.297982SP
2610.710.905014268298.12112.6497.364344104.29309141SP
5218.0119.832617553190.81112.6482.1375463896.58335575SP
1564.544.35366321442104.28112.6471.5710490.44394955SP
26032.9443.410648392275.88112.6450.19151086282.75759669SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
IMNNImunon Inc
$ 2.60
(118.49%)
5.44M
JTAIJet AI Inc
$ 0.40
(33.82%)
7.94M
TTOOT2 Biosystems Inc
$ 5.70
(20.25%)
128.23k
ISPOInspirato Inc
$ 6.27
(19.66%)
1.35M
AISPAirship AI Holdings Inc
$ 4.20
(17.65%)
504.42k
QXOQXO Inc
$ 11.99
(-80.18%)
1.27M
SYMSymbotic Inc
$ 29.19
(-18.07%)
762.4k
NRSNNeuroSense Therapeutics Ltd
$ 0.641
(-16.86%)
1.62k
CLDXCelldex Therapeutics Inc
$ 35.95
(-14.38%)
89.23k
LIPOLipella Pharmaceuticals Inc
$ 0.775
(-13.81%)
1.09M
NVDANVIDIA Corporation
$ 111.65
(0.05%)
8.68M
TLRYTilray Brands Inc
$ 1.98
(8.49%)
8.68M
JTAIJet AI Inc
$ 0.40
(33.82%)
7.94M
OXLCOxford Lane Capital Corporation
$ 5.57
(0.18%)
7.49M
SPCBSuperCom Ltd
$ 0.2041
(7.42%)
5.7M

Discussion

View Full Feed
StayHumble StayHumble 1 minute ago
Kramer NakedShorted✅4Bill+$DBMM shares 4Charity?✅✅✅


Source: TDA 2014 Chart https://investorshub.advfn.com/uimage/uploads/2023/1/29/cpbxb2014_dbmm_trade_data.png Source: https://fintel.io/s/us/dbmm
https://investorshub.advfn.com/uimage/uploads/2023/1/29/hnfvkchart.png
DBMM
Denisk Denisk 1 minute ago
here is what was in Holft emply,emt agreement
Definitions
. For purposes of this Agreement:
(i) “
Change in Control
” means:
(A) the sale of all or substantially all of the assets of the Company and its subsidiaries to one or more third parties in atransacti
AMRN
Lime Time Lime Time 1 minute ago
We go to stock specific boards to talk about the stocks and only the stock, whether that be positive or negative. But we see political advertisement right where we click reply, or click to post. How is that such a thing, where politics aren't allowed on stock specific boards. "Do as we say, not as w
QuantumTravesty QuantumTravesty 1 minute ago
Bud as many years as you’ve been in Hiru and he’s been with us you should know he does this on his 7/11 night shift salary as a public service.
Bless his heart.
HIRU
Poundthetable Poundthetable 1 minute ago
Lake Ronkonkoma on Long Island is Bottomless too
SMCE
SloGin SloGin 2 minutes ago
Yeah quite entertaining a Quantum monkey and a Waterboy stuck in the 1990s!
HIRU
jonsmile jonsmile 2 minutes ago
161k is super low unfortunately no one had faith in Mangement
BMXI
Rizinup Rizinup 2 minutes ago
I agree, Screw the FDA while they keep jacking this around do the human trials in Europe or some 3rd world country, get the product to market and start saving/extending people’s lives globally all IMO
RDGL
Alpha14 Alpha14 2 minutes ago
The FOXO deal close yet?
FOXO
Tiger Money Tiger Money 2 minutes ago
It is a cure for mammals whom have cancerous tumors.
RDGL
al44 al44 2 minutes ago
In need of Bud Light treatment-

But the ban is a good first step
https://media.gettr.com/group7/getter/2024/07/29/10/c6a1defa-f7e0-c0c7-0f44-eb1f47ccfc83/6e01af021bd2603f779edc154761dd78_768x0.png
trademax42 trademax42 3 minutes ago
Don't know about a ceiling put on it. Momentum and news on fundamentals are driving this bus. In OTC, the bus slows down or reverses its acceleration if there is the fear of dilution followed by a RS. None of these fear exists at this time. imo

.0077 by Friday would be my max for Fr
HIRU
Whalatane Whalatane 3 minutes ago
Always good to have some bears on a board .....seriously .
I'm buying MU at roughly 30% of its high, expecting it may well hit $100 a share before it rebounds .

Kiwi
MU
IceCold8 IceCold8 3 minutes ago
We all have,some of us multiple times. Didn't you have a private audience with him,to answer shareholder questions???
CGAC
pumkin farmer pumkin farmer 3 minutes ago
Dude ,you follow 12000 OTC stocks ? amazing 🤔
RNVA
SloGin SloGin 3 minutes ago
Say what? What list Hiru on Euro exchanges? Where does it say that? He is saying he is advertising Hiru to European & Middle East Countries tradersto buy HIRU stock! Asking supporters on X not to glorify bashers posts with answers!
HIRU
Itchy palm Itchy palm 4 minutes ago
Empty podium empty head no different 😁
rogers711 rogers711 4 minutes ago
Has it not cured all the animals it has treated though?
RDGL
delerious1 delerious1 4 minutes ago
Post a tune or make a comment...
ipiros ipiros 4 minutes ago
Less clear than other tweets, true. What's up with the trade show link, is the Sheik in Vegas looking for another business venture?
HIRU
Taur1112 Taur1112 4 minutes ago
Great news today! Serious credibility, money and talent on board. This is going to go nuts soon.
MONI
ignatiusrielly35 ignatiusrielly35 5 minutes ago
Possible but I cannot imagine AVXL distributing a drug throughout Europe on its own.
AVXL
Runaway27 Runaway27 5 minutes ago
I realize that i may be screwed, blued and tattooed like most on this thread that are holding IV but what about UDF V, are they combining all or just concentrating on one of the issues, I've been holding 2700 shares of UDF V and only get a smidgeon of a dividend every 3 months which amounts to a Sam
Steady_T Steady_T 6 minutes ago
Eligibility request is the first step according to the EMU guidelines.
Steps involved in obtaining an
EU marketing authorisation
1. Submission of eligibility request.
(At the earliest 18 months and at the latest
7 months in advance of submission.)
2. Notific
AVXL